标题
Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target
作者
关键词
-
出版物
ONCOGENE
Volume 36, Issue 25, Pages 3588-3598
出版商
Springer Nature
发表日期
2017-02-07
DOI
10.1038/onc.2016.510
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma
- (2017) Shoji Hanada et al. Cancer Biomarkers
- Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway
- (2016) Brian P. Ziemba et al. BIOPHYSICAL JOURNAL
- Secretome protein signature of human pancreatic cancer stem-like cells
- (2016) Jessica Brandi et al. Journal of Proteomics
- Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
- (2015) H. I. Wettersten et al. CANCER RESEARCH
- Emerging therapeutic approaches in renal cell carcinoma
- (2015) Hiral Parekh et al. Expert Review of Anticancer Therapy
- Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma
- (2015) Wael Naboulsi et al. JOURNAL OF PROTEOME RESEARCH
- Understanding multicellular function and disease with human tissue-specific networks
- (2015) Casey S Greene et al. NATURE GENETICS
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization
- (2015) Timothy D. Rohrbach et al. PLoS One
- Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
- (2015) Ching-Hsien Chen et al. Oncotarget
- Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma
- (2015) Kyung Seok Han et al. NEOPLASIA
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- A Novel Predictor of Cancer Malignancy: Up-regulation of Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation in Lung Cancer
- (2014) Ching-Hsien Chen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation Site Domain in Lung Cancer. Mechanisms and Therapeutic Implications
- (2014) Ching-Hsien Chen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4
- (2014) Christina A. von Roemeling et al. CANCER RESEARCH
- Molecular Biomarkers in Advanced Renal Cell Carcinoma
- (2014) P. Maroto et al. CLINICAL CANCER RESEARCH
- Renal cell carcinoma
- (2014) Daniel Su et al. CURRENT OPINION IN ONCOLOGY
- The role of HIF1α in renal cell carcinoma tumorigenesis
- (2014) Lorraine J. Gudas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma
- (2014) Y Yang et al. LEUKEMIA
- Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival
- (2014) M Bickeböller et al. ONCOGENE
- Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy
- (2014) Danielle Ferraro et al. Therapeutic Advances in Medical Oncology
- Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo
- (2013) Krista Rombouts et al. CANCER LETTERS
- The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma
- (2013) T. K. Choueiri et al. CLINICAL CANCER RESEARCH
- Emerging antiangiogenics for renal cancer
- (2013) Charlotte Domblides et al. EXPERT OPINION ON EMERGING DRUGS
- Targeting angiogenesis in renal cell carcinoma
- (2013) Edwin M Posadas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
- (2013) Brigid C. Browne et al. FEBS Journal
- A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis
- (2013) C-H Chen et al. ONCOGENE
- Regorafenib (BAY 73–4506): Stromal and Oncogenic Multikinase Inhibitor with Potential Activity in Renal Cell Carcinoma
- (2013) Kamarul Zaki et al. Current Oncology Reports
- Novel tyrosine kinase inhibitors for renal cell carcinoma
- (2013) Tanya B Dorff et al. Expert Review of Clinical Pharmacology
- MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma
- (2012) J. S. Jarboe et al. CLINICAL CANCER RESEARCH
- Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
- (2012) Tim Eisen et al. LANCET ONCOLOGY
- The Hypoxia-Associated Factor Switches Cells from HIF-1 - to HIF-2 -Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
- (2011) M. Y. Koh et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year
- (2011) Marine Gross-Goupil et al. Current Urology Reports
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- PhosphoMARCKS drives motility of mouse melanoma cells
- (2010) Xiangyu Chen et al. CELLULAR SIGNALLING
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- The MARCKS Protein Plays a Critical Role in Phosphatidylinositol 4,5-Bisphosphate Metabolism and Directed Cell Movement in Vascular Endothelial Cells
- (2010) Hermann Kalwa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidermal Growth Factor Receptor Variant III-Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression
- (2009) J. Micallef et al. CANCER RESEARCH
- VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy
- (2009) C. Lance Cowey et al. Current Oncology Reports
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now